Please note this webinar is hosted by
Jazz Pharmaceuticals has determined the content and speakers for this educational session
CBMTG is happy to provide webinars free of charge to members of the Society!
If you are a member, please be sure to login with your username and password before registering for this webinar.
Non-Members: $90 plus tax
Date: Wednesday, November 21, 2018
Time: 9:00am PT/ 12:00pm ET
Topic: Early Vascular Complications Past Hematopoietic Stem Cell Transplantation (HSCT)
Speakers: Mohamed Elemary, MBBCh, MSc, PhD
Dr. Mohamed Elemary is n associate professor of hematology and director of Stem Cell Transplant program at Saskatoon Cancer Center, University of Saskatchewan.
He graduated from School of Medicine, Cairo University in 1993, had residency training in internal medicine, followed by residency in hematology and fellowship in bone marrow transplant, last was at Princess Margaret hospital, University of Toronto before moving to Saskatoon in 2010. His main interest is in the treatment of malignant hematology, mainly Leukemia, MDS, Myeloma and lymphoma. In addition to hematology, Dr. Elemary has participated in almost 2500 allogeneic and autologous stem cell transplants in various transplant centres. He is interested in clinical research and the principle investigator of many clinical trials in hematological malignancies and stem cell transplant.
Early endothelial complications after HSCT pose quite a challenge in the diagnosis and treatment. There is no specific diagnostic criteria and they have overlapping clinical manifestations. In this presentation I will review the different clinical presentations of early endothelial damage syndromes. I will also discuss how to differentiate between them according to the available diagnostic tools. Management guidelines will be also discussed.
1. Review the clinical presentations of different early endothelial damage syndromes after HSCT
2. Review the challenges and diagnostic tools of early endothelial damage syndromes after
3. Discuss management plan of different early endothelial damage syndromes after HSCT